103440-53-5

Basic information

• Product Name: 4-iodo-2-Methyl-benzoic acid Methyl ester
• Synonyms: 4-iodo-2-Methyl-benzoic acid Methyl ester;Methyl 4-iodo-2-Methylbenzoate
• CAS NO: 103440-53-5
• Molecular Formula: C₉H₉IO₂
• Molecular Weight: 276.07103
• Mol File: 103440-53-5.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: 4-iodo-2-Methyl-benzoic acid Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-iodo-2-Methyl-benzoic acid Methyl ester(103440-53-5)
• EPA Substance Registry System: 4-iodo-2-Methyl-benzoic acid Methyl ester(103440-53-5)

Safety Data

• Hazardous Substances Data: 103440-53-5(Hazardous Substances Data)

Usage

Uses

Used in Chemical Research:
4-iodo-2-Methyl-benzoic acid Methyl ester is used as a research compound for studying its chemical properties and potential applications in various chemical reactions. Its unique structure with an iodine atom and a methyl group allows for exploration of its reactivity and behavior in different chemical environments.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 4-iodo-2-Methyl-benzoic acid Methyl ester is utilized as a starting material or intermediate in the synthesis of various pharmaceutical compounds. Its presence in the molecule can influence the biological activity and pharmacological properties of the final product, making it a valuable component in drug development.
Used in Organic Synthesis:
4-iodo-2-Methyl-benzoic acid Methyl ester is employed as a building block in organic synthesis, where it can be further modified or used to create more complex organic molecules. Its versatility in chemical reactions makes it a useful component in the synthesis of various organic compounds.
Used in Analytical Chemistry:
4-iodo-2-Methyl-benzoic acid Methyl ester can also be used in analytical chemistry as a reference material or standard for the development and validation of analytical methods. Its distinct chemical properties can be exploited to evaluate the performance of analytical techniques and instruments.

Upstream product

• 67-56-1 methanol 
• 133232-58-3 4-iodo-2-methylbenzoic acid 
• 6933-47-7 methyl 4-amino-2-methylbenzoate 

Downstream Products

• 341011-40-3 methyl 2-(bromomethyl)-4-iodobenzoate 
• 341030-79-3 Methyl-2-methyl-4-trifluormethyl-benzoat 
• 1206640-72-3 C₁₁H₁₂INO 
• 1331886-87-3 4-[5-(3,5-dichloro-phenyl)-2-oxo-5-trifluoromethyl-2,5-dihydro-furan-3-yl]-2-methyl-benzoic acid methyl ester 
• 897958-99-5 5-iodoisoindolin-1-one 
• 1313397-67-9 2-ethyl-5-(5-((5-oxo-2-thioxoimidazolidin-4-ylidene)methyl)thiophen-2-yl)isoindolin-1-one 
• 1313397-81-7 2-(3-(4-methylpiperazin-1-yl)propyl)-5-(5-((5-oxo-2-thioxoimidazolidin-4-ylidene)methyl)thiophen-2-yl)isoindolin-1-one 

Relevant articles and documents

SUBSTITUTED OXOISOINDOLINE COMPOUNDS FOR THE TREATMENT OF CANCER

Disclosed are compounds of Formula (I) or a salt thereof, wherein Ring A is a carbon-linked ring; and Ring A, R1, and n are defined herein. Also disclosed are methods of using such compounds to inhibit Helios protein, and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment of viral infections and proliferative disorders, such as cancer.

INHIBITORS OF HEPATITIS C VIRUS POLYMERASE

The present invention provides, among other things, compounds represented by the general Formula I: (I) and pharmaceutically acceptable salts thereof, wherein L and A (and further substituents) are as defined in classes and subclasses herein and compositions (e.g., pharmaceutical compositions) comprising such compounds, which compounds are useful as inhibitors of hepatitis C virus polymerase, and thus are useful, for example, as medicaments for the treatment of HCV infection.

[1, 2, 4] TRIAZOLO [1, 5-A] PYRIDINES AS JAK INHIBITORS

Novel [1,2,4]triazolo[1,5-a]pyridine compounds are disclosed that have a Formula represented by the following: (I). The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, joint disease, inflammation, and others.

Doxepin analogs and methods of use thereof

The invention relates to novel antihistamines and methods of modulating sleep by administering a doxepin analog or a pharmaceutically effective salt thereof.

Aryl and heteroaryl (phosphinylmethyl)phosphonate squalene synthetase inhibitors and method

Phosphonic acid squalene synthetase inhibitors are provided which are effective in lowering serum cholesterol and have the formula STR1 wherein m is 0 to 3, n is 1 to 5, Y1 and Y2 are H or halogen, R2, R3 and R4 are H, metal ion, C1 to C8 alkyl, C3 to C12 alkenyl, or prodrug ester, and R1 is a substituted or unsubstituted heteroaryl group or a substituted phenyl group.